ProQR Therapeutics (PRQR) Tax Provisions (2017 - 2025)
ProQR Therapeutics (PRQR) reported Tax Provisions of $43069.6 for Q4 2025, up 110.23% on a YoY basis from $20486.9 in Q4 2024, and up 311.38% sequentially from -$20375.3 in Q2 2025.
ProQR Therapeutics (PRQR) Tax Provisions (2017 - 2025) Analysis & Trends
ProQR Therapeutics (PRQR) has 9 years of Tax Provisions data on file, last reported at $43069.6 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 110.23% year-over-year to $43069.6; the trailing twelve-month figure through Dec 2025 stood at -$398332.3 (down 90.67% YoY), and the FY2025 full-year result was $22116.8, up 110.51% from the prior year.
- Tax Provisions climbed to $43069.6 in Q4 2025, from -$20375.3 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $215377.5 in Q2 2024 to a low of -$421026.6 in Q4 2024.
- A 5-year average of -$19416.7 and a median of -$14409.5 in 2025 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions plunged 426.79% in 2021 and surged 878.34% in 2022, its largest moves.
- Tracing PRQR's Tax Provisions over 5 years: stood at -$25167.4 in 2021, then surged by 878.34% to $195887.5 in 2022, then plunged by 188.43% to -$173226.3 in 2023, then slumped by 143.05% to -$421026.6 in 2024, then surged by 110.23% to $43069.6 in 2025.
- Business Quant data shows PRQR's Tax Provisions at $43069.6 in Q4 2025, -$20375.3 in Q2 2025, and -$421026.6 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | ProQR Therapeutics | 182.23 Mn | 138.42 Mn | - | 43,069.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,069.61 |
| Jun 30, 2025 | -20,375.27 |
| Dec 31, 2024 | -421,026.59 |
| Jun 30, 2024 | 215,377.52 |
| Mar 31, 2024 | -3,259.09 |
| Dec 31, 2023 | -173,226.33 |
| Sep 30, 2023 | 44,632.21 |
| Jun 30, 2023 | 45,734.82 |
| Dec 31, 2022 | 195,887.49 |
| Sep 30, 2022 | -69,570.93 |
| Jun 30, 2022 | -21,341.13 |
| Mar 31, 2022 | -7,856.36 |
| Dec 31, 2021 | -25,167.36 |
| Sep 30, 2021 | -41,275.06 |
| Jun 30, 2021 | -63,826.39 |
| Mar 31, 2021 | -8,443.65 |
| Dec 31, 2020 | -45,307.01 |
| Sep 30, 2020 | -87,605.79 |
| Jun 30, 2020 | -12,116.06 |
| Dec 31, 2019 | -75,268.36 |